Simon Tanguay
Professor
M Elhilali and D Azrieli Chair in Urologic Sciences
Chair, Division of Urology
MD, FRCSC
Urologic Oncology Fellowship
MD Anderson Cancer Center
Precision medicine in kidney cancer
Outcome predictors for kidney cancer
Urologic oncology
Kidney Cancer
Dr Tanguay is currently Professor and Chair of the Division of Urology at 91Ë¿¹ÏÊÓƵ and hold the M. Elhilali and D. Azrieli Chair in urologic sciences.
Dr Tanguay completed his residency training at 91Ë¿¹ÏÊÓƵ and a fellowship in Urologic Oncology at the University of Texas M. D. Anderson Cancer Center.
Dr Tanguay served a member of the executive committee of the Genito-Urinary group at the National Cancer Institute of Canada and as the Chair of the Canadian Kidney Cancer information system from 2009 to 2016. He was the General Secretary of the Société Internationale d’Urologie from 2011 to 2016 and served as President from 2018-2019.
His research interests are on the development of precision medicine in kidney cancer with the aim to discover new strategy to detect cancer recurrence and develop novel therapeutic targets. Dr Tanguay is the Chair of the medical advisory board of Kidney Cancer Canada